Suscriptores   Asóciese  
Textos Completos Autorizados
PAPEL DE LAS INFECCIONES VIRALES EN EL ASMA

v-estudie-lo-mejor.gif
Expertos Invitados




Artículos relacionadosArtículos relacionadosArtículos relacionados
Artículos afines de siicsalud publicados en los últimos 4 meses
USO DE PLASMA DE CONVALECIENTE EN PACIENTES CON SÍNDROME DE DIFICULTAD RESPIRATORIA AGUDA INDUCIDO POR LA COVID-19
New England Journal of Medicine 389:1590-1600
Difundido en siicsalud: 25 ene 2024
PAPEL DEL MICOBIOMA EN LAS ENFERMEDADES ATÓPICAS
Journal of Allergy and Clinical Immunology 152(6):1368-1375
Difundido en siicsalud: 22 mar 2024

PAPEL DE LAS INFECCIONES VIRALES EN EL ASMA

(especial para SIIC © Derechos reservados)
Las infecciones virales respiratorias han sido involucradas en el origen y en las exacerbaciones de los síntomas del asma en una variedad de formas. Cada vez hay más indicios de que las infecciones virales están estrechamente relacionadas con sibilancias en la niñez y sugieren que la bronquiolitis grave en la primera infancia puede predisponer a asma crónica infantil.
papadopoulos.jpg Autor:
Nikolaos G. Papadopoulos
Columnista Experto de SIIC

Institución:
University of Athens

Artículos publicados por Nikolaos G. Papadopoulos 		Artículo comentado
Dora Felipoff
Hospital Córdoba, Córdoba, Argentina
Coautor
Paraskevi Xepapadaki* 
MD, PhD, University of Athens, Atenas, Grecia*
Recepción del artículo
2 de Agosto, 2005 		Aprobación
9 de Agosto, 2005
Primera edición
13 de Marzo, 2006 		Segunda edición, ampliada y corregida
7 de Junio, 2021

PAPEL DE LAS INFECCIONES VIRALES EN EL ASMA

Resumen
Las infecciones virales respiratorias han sido involucradas en el origen y en las exacerbaciones de los síntomas del asma en una variedad de formas. Cada vez hay más indicios de que las infecciones virales están estrechamente relacionadas con sibilancias en la niñez y sugieren que la bronquiolitis grave en la primera infancia puede predisponer a asma crónica infantil; por otra parte, podría representar un marcador de individuos susceptibles. Por el contrario, las infecciones leves repetidas en los primeros años brindarían un efecto protector contra la aparición de asma o atopia mediante la desviación del sistema inmunitario hacia respuestas Th1. Sin embargo, la información relacionada con esta hipótesis no es firme en lo que a virus se refiere. Por otra parte, en presencia de asma, el papel de las infecciones virales sobre las exacerbaciones está bien establecido. Varios factores, como la presencia de atopia, el momento en el que se produce la exposición y la gravedad de las infecciones, interactúan en la relación entre asma e infección. En este artículo se revisan datos acerca de la participación de las infecciones virales en la aparición y progresión del asma.

Palabras clave
Virus respiratorios, rinovirus, VRS, bronquiolitis, asma, atopia, Th1, Th2


Artículo completo
(castellano)
Extensión:  +/-9.38 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

The role of viral infections in asthma

Abstract
Respiratory viral infections have been implicated in the origin and exacerbation of asthma symptoms in a variety of ways. A growing body of evidence indicates that viral infections are closely linked to infantile wheezing and suggest that severe bronchiolitis in early infancy may predispose to chronic childhood asthma. Alternatively, it could represent a marker of susceptible individuals. In contrast, mild repetitive infections in early years may provide a protective role against the development of asthma or atopy by switching the immune system towards Th1 responses. However, evidence on this hypothesis is not consistent as far as viruses are concerned. On the other hand, in the presence of asthma, the role of viral infections on exacerbations is well established. Several factors, such as the presence of atopy, timing of the exposure and severity of the infections, interactively contribute to the asthma-infection relationship. In the present report, recent data on the involvement of viral infections in the development and progression of asthma are reviewed.

Key words
Respiratory viruses, rhinovirus, RSV, bronchiolitis, asthma, atopy, Th1-Th2


Full text
(english)
 para suscriptores/ assinantes
Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Alergia, Infectología
Relacionadas: Diagnóstico por Laboratorio, Inmunología, Medicina Interna, Neumonología



Comprar este artículo
Extensión: 9.38 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Nikolaos G Papadopoulos, University of Athens, Atenas, Grecia
Bibliografía del artículo
1. Xepapadaki P, Psarras S, Bossios A, et al. Human Metapneumovirus as a causative agent of acute bronchiolitis in infants. J Clin Virol 30(3):267-270, 2004.
2. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 165(9):1285-1289, 2002.
3. Peebles RS, Jr. Viral infections, atopy, and asthma: is there a causal relationship J Allergy Clin Immunol 113(1 Suppl):S15-18, 2004.
4. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354(9178):541-545, 1999.
5. Noble V, Murray M, Webb MS, et al. Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child 76(4):315-319, 1997.
6. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171(2):137-141, 2005.
7. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161(5):1501-1507, 2000.
8. Korppi M, Piippo-Savolainen E, Korhonen K, et al.Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol 38(2):155-160, 2004.
9. Piippo-Savolainen E, Remes S, Kannisto S, et al. Asthma and lung function 20 years after wheezing in infancy: results from a prospective follow-up study. Arch Pediatr Adolesc Med 158(11):1070-1076, 2004.
10. Gómez R, Colas C, Sebastian A, et al. Respiratory repercussions in adults with a history of infantile bronchiolitis. Ann Allergy Asthma Immunol 93(5):447-451, 2004.
11. Kneyber MCJ, Steyerberg EW, de Groot R, et al. Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr 89(6):654-660, 2000.
12. Kotaniemi-Syrjanen A VR, Reijonen TM, Waris M, et al. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma J Allergy Clin Immunol 111(1):66-71, 2003.
13. Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 196(10):1381-1386, 2002.
14. Schwarze J, O'Donnell DR, Rohwedder A, et al. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 169(7):801-805, 2004.
15. Openshaw PJ, Yamaguchi Y, Tregoning JS. Childhood infections, the developing immune system, and the origins of asthma. J Allergy Clin Immunol 114(6):1275-1277, 2004.
16. Wenzel SE, Gibbs RL, Lehr MV, et al. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med 112(8):627-633, 2002.
17. Piedimonte G. The association between respiratory syncytial virus infection and reactive airway disease. Respir Med 96 Suppl B:S25-29, 2002.
18. Busse WW, Banks-Schlegel SP, Larsen GL. Effects of growth and development on lung function. Models for study of childhood asthma. Am J Respir Crit Care Med 156(1):314-319, 1997.
19. Gern JE, Rosenthal LA, Sorkness RL, et al. Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol 115(4):668-774, 2005.
20. Papadopoulos NG, Johnston SL. The role of viruses in the induction and progression of asthma. Curr Allergy Asthma Rep 1(2):144-152, 2001.
21. Infante-Rivard C, Amre D, Gautrin D, et al. Family size, day-care attendance, and breastfeeding in relation to the incidence of childhood asthma. Am J Epidemiol 153(7):653-658, 2001.
22. Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 343(8):538-543, 2000.
23. Gereda JE, Leung DY, Thatayatikom A, et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355(9216):1680-1683, 2000.
24. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 109(3):379-392, 2002.
25. Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 288(8):963-972, 2002.
26. Von Mutius E. Environmental factors influencing the development and progression of pediatric asthma. J Allergy Clin Immunol 109(6S):S525-532, 2002.
27. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 347(9018):1792-1796, 1996.
28. Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorder. Science 275(5296):77-79, 1997.
29. Strannegard IL, Larsson LO, Wennergren G, et al. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 53(3):249-254, 1998.
30. Paunio M, Heinonen OP, Virtanen M, et al. Measles history and atopic diseases: a population-based cross-sectional study. JAMA 283(3):343-346, 2000.
31. Matricardi PM, Rosmini F, Riondino S, et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 320(7232):412-417, 2000.
32. Linneberg A, Ostergaard C, Tvede M, et al. IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J Allergy Clin Immunol 111(4):847-853, 2003.
33. Matricardi PM, Bonini S. High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the Hygiene hypothesis Clin Exp Allergy 30(11):1506-1510, 2000.
34. Illi S, Von Mutius E, Lau S, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. BMJ 322(7283):390-395, 2001.
35. Celedon JC, Litonjua AA, Ryan L, et al. Day care attendance, respiratory tract illnesses, wheezing, asthma, and total serum IgE level in early childhood. Arch Pediatr Adolesc Med 156(3):241-245, 2002.
36. Barends M, de Rond LG, Dormans J, et al. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice. Clin Exp Allergy 34(3):488-496, 2004.
37. Dahl ME, Dabbagh K, Liggitt D, et al.Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 5(3):337-343, 2004.
38. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310(6989):1225-1229, 1995.
39. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 307:982-986, 1993.
40. Grissell TV, Powell H, Shafren DR, et al. IL-10 Gene Expression in Acute Virus-induced Asthma. Am J Respir Crit Care Med 172(4):433-439, 2005.
41. Platts-Mills TA, Rakes G, Heymann PW. The relevance of allergen exposure to the development of asthma in childhood. J Allergy Clin Immunol 105(2 Pt 2):S503-508, 2000.
42. Brouard J, Freymuth F, Toutain F, et al. Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children. Arch Pediatr 9 Suppl 3:365s-371s, 2002.
43. Wark PA, Johnston SL, Moric I, et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19(1):68-75, 2002.
44. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 115(1):132-138, 2005.
45. Corne JM, Lau L, Scott SJ, et al. The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med 163(5):1101-1107, 2001.
46. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis 181(6):1875-1884, 2000.
47. Mosser AG, Brockman-Schneider R, Amineva S, et al. Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 185(6):734-743, 2002.
48. Ghildyal R, Dagher H, Donninger H, et al. Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor. J Med Virol 75(4):608-615, 2005.
49. Mosser AG, Vrtis R, Burchell L, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 171(6):645-651, 2005.
50. Papadopoulos NG, Papi A, Meyer J, et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 31(7):1060-1066, 2001.
51. Walter MJ, Kajiwara N, Karanja P, et al. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 193(3):339-351, 2001.
52. Zheng T, Zhu Z, Wang J, et al. IL-11: insights in asthma from overexpression transgenic modeling. J Allergy Clin Immunol 108(4):489-496, 2001.
53. Walter MJ, Morton JD, Kajiwara N, et al. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 110(2):165-175, 2002.
54. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 324(7340):763, 2002.
55. Trigg CJ, Nicholson KG, Wang JH, et al. Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin Exp Allergy 26(6):665-676, 1996.
56. Ávila PC. Interactions between allergic inflammation and respiratory viral infections. J Allergy Clin Immunol 106:829-831, 2000.
57. de Kluijver J, Evertse CE, Sont JK, et al. Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure Am J Respir Crit Care Med 168(10):1174-1180, 2003.
58. Davies DE, Wicks J, Powell RM, et al. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 111(2):215-225, 2003.
59. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201(6):937-947, 2005.
60. Papadopoulos NG, Stanciu LA, Papi A, et al. A defective type 1 response to rhinovirus in atopic asthma. Thorax 57(4):328-332, 2002.
61. Brooks GD, Buchta KA, Swenson CA, et al. Rhinovirus-induced interferon- and airway responsiveness in asthma. Am J Respir Crit Care Med 168:1091-1094, 2003.
62. Folkerts G, Busse WW, Nijkamp FP, et al. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 157(6 Pt 1):1708-1720, 1998.
63. Gern JE, Calhoun W, Swenson C, et al. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 155(6):1872-1876, 1997.
64. Xepapadaki P, Papadopoulos NG, Bossios A, et al. Duration of post-viral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol 116(2):299-304, 2005.
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
Artículos relacionadosMás relacionadosAtículos relacionados
INTRODUCCIÓN DE ALIMENTOS Y RIESGO DE ALERGIA
Advances In Nutrition :1-13
Difundido en siicsalud: 26 dic 2023
ua31618
Acerca de SIIC   Estructura de SIIC   Fuentes informativas  

Sociedad Iberoamericana de Información Científica

Copyright siicsalud© 1997-2024 ISSN siicsalud: 1667-9008
ua31517